Skip to main content
Signal8

Marpai, Inc. (MRAI) Form 10-Q — Nov 12, 2026

$MRAIForm 10-QFiled Nov 12, 2026, 4:16 PM ET0001213900-26-118949Original filing

Marpai's Q3 2026 10-Q discloses substantial doubt about its ability to continue as a going concern, with just $360 thousand of unrestricted cash, $5.5 million of negative working capital, and $11.1 million of net loss on nine-month revenue of $13.0 million. The company funded itself via a $12.1 million Series A preferred stock offering in July 2026, a $2.0 million vendor financing advance, and CEO loans, but remains heavily leveraged with $18.8 million owed to AXA (10% compounding interest) and $7.6 million of convertible debentures.

Key figures

Revenue
4424000
Total Debt
24400000
Revenue Yoy
Q3 +9.6%; nine months -7.6%
Total Assets
10812000
Cash Position
360000
Shares Outstanding
26915941
Axa liability
18764000
Restricted cash
7411000
Accumulated deficit
126446000
Net loss nine months
11052000
Preferred dividend rate
8% cumulative
Common stock equivalents
23016333
Negative working capital
5500000
Vendor financing advance
2000000
Convertible debentures net
7586000
Preferred offering gross proceeds
12100000
Operating cash outflow nine months
11557000

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.